Clinical Trials
166 trialsGRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Duke University
Loupe-Based Intraoperative Fluorescence Imaging
University of Kentucky
Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
Xiangya Hospital of Central South University
CSF-IMR
Medical University of Warsaw
MANGO
University of Sydney
SHINE-GLIO
University Hospital, Essen
Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
Rigshospitalet, Denmark
SHAM INDYGO/DO
University Hospital, Lille
ResPGlioma
Universita degli Studi di Genova
MRinRT
Swansea Bay University Health Board
FCI-Glioblastoma Study
University of Aberdeen
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
Columbia University
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
APT-HGG
IRCCS Ospedale San Raffaele
Targeted Pediatric High-Grade Glioma Therapy
Nationwide Children's Hospital
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy
Medical College of Wisconsin
UFGAG
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
Memorial Sloan Kettering Cancer Center
ERROR
Maastricht Radiation Oncology
GLIOTARG
Blokhin's Russian Cancer Research Center
FLUO-LB
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
Thomas Jefferson University
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
Baptist Health South Florida
Key LARGO
Duke University
FET-TREAT
Sunnybrook Health Sciences Centre
LAMB-G
Duke University
Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
Medical College of Wisconsin
Clinical and Treatment Determinant of Prognosis in Glioblastoma
Assiut University
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
Dartmouth-Hitchcock Medical Center
ReGIT
Indiana University
BORDEAUX-GLIO
University Hospital, Bordeaux
A Multicenter, Prospective Study for Glioblastoma Patients
Larissa University Hospital
APPOINT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SINUE
Universitat Politècnica de València
GBrecurr
University Hospital, Bordeaux
GUAVA
Royal North Shore Hospital
ONCOhabitats
Universitat Politècnica de València
ALBATROSS
Universitat Politècnica de València
BIOhabitats
Universitat Politècnica de València
OLFGBM
University Hospital, Essen
Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
University of Michigan Rogel Cancer Center
Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
Washington University School of Medicine
Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
Zhejiang Provincial People's Hospital
Tryptophan Metabolism in Human Brain Tumors-Novocure
Wayne State University
GBM-FLUX2
AdventHealth Translational Research Institute
MARGA
University of Zurich
CSF Proteomic Characterization of Glioblastomas
Univeridad Autonoma de Guadalajara
EVIDENT
Sheffield Teaching Hospitals NHS Foundation Trust
IMMUNOGLIO
Centre Georges Francois Leclerc
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Chungnam National University Hospital